Has Andrew Boulet, MD received payments from drug or device companies?

Yes. Drug and device makers reported $879 in general payments to Andrew Boulet, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Boulet, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Boulet, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Boulet, MD

Cardiovascular Disease · Spokane, WANPI 1336195064

Payments from drug & device makers

$879in general payments, 2019–2025

Across 11 payments — averaging $79.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$238
Bayer$207
Novo Nordisk$168
E.r. Squibb & Sons, L.L.C.$125
United Therapeutics Corporation$108
Boston Scientific$33

What the payments were for

Food & beverage$879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	2	$238
Bayer	2	$207
Novo Nordisk	3	$168
E.r. Squibb & Sons, L.L.C.	1	$125
United Therapeutics Corporation	1	$108
Boston Scientific	2	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$879 in reported general payments places this provider in the 50th percentile of 370 cardiovascular disease providers in Washington.

See all cardiovascular disease providers in Washington →

Medicare billing

Part B allowed, 2024

$130,818

Medicare patients

1,029

Services billed

1,888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	235	$316,732
JardianceEmpagliflozin	142	$169,689
XareltoRivaroxaban	116	$131,866
Repatha SureclickEvolocumab	99	$98,821
EntrestoSacubitril/Valsartan	58	$75,222
Metoprolol Succinate	681	$14,822
Praluent PenAlirocumab	21	$14,695
Potassium Chloride	464	$10,870
Dabigatran EtexilateDabigatran Etexilate Mesylate	21	$7,511
Atorvastatin Calcium	513	$6,966
Ezetimibe	202	$4,579
Diltiazem 24hr Er (Cd)Diltiazem Hcl	155	$4,479
Dofetilide	16	$3,506
CorlanorIvabradine Hcl	11	$3,108
Losartan Potassium	281	$2,993

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Spokane

Bryan FuhsSpokane$268K
John EverettSpokane$163K
Kavisha SinghSpokane$63K
Adam NoyesSpokane$17K
Romeo PavlicSpokane$14K
Vinay MalhotraTacoma$5M
Francis KimSeattle$1.7M
Ahmad SlimTacoma$1.1M
Kelley BranchSeattle$715K
Robert BersinBellevue$677K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →